Sweeteners
added sugar increases diabetes risk
Part of: • Added sugar
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Unlike the confounded diet-soda association, the link between sugar-sweetened beverages and type-2 diabetes is robust and only partly explained by weight gain: multiple dose-response meta-analyses of prospective cohorts show higher risk per daily serving, with mechanistic support (rapid glycemic/insulin load, fructose-driven hepatic fat).
The evidence (5)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Malik, Popkin, Bray, Despres, Willett, Hu 2010 · Diabetes Care 2010;33(11):2477-2483 | meta-analysis | supports | moderate | Random-effects meta-analysis of 8 prospective cohorts (9 data points), 310,819 participants, 15,043 incident cases: 'the pooled RR for type 2 diabetes was 1.26 (95% CI 1.12-1.41)' for highest vs lowest quantile of SSB intake (most often none or <1 serving/month vs >=1-2 servings/day); dose-response 'RR 1.25 (95% CI 1.10-1.42)' per 1 12-oz serving/day. Cohorts only, no trials; 'there was significant heterogeneity among studies in both analyses' (I2 66%) and 'residual confounding by unmeasured or imperfectly measured factors cannot be ruled out.' |
| Imamura F, O'Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG 2015 · BMJ 2015;351:h3576 | meta-analysis | supports | moderate | BMJ/MRC meta-analysis of 17 prospective cohorts (38,253 incident T2D cases / 10.1 million person years; no trials, no industry funding). SSB per one serving/day: RR 1.18 (1.09 to 1.28, I2=89%) before and 1.13 (1.06 to 1.21, I2=79%) after adjustment for adiposity - 'When adjusted for potential mediation and confounding by adiposity, the association was attenuated, with the incidence increased by 13% per serving/day'. Multivariable adjustment moved it only from 1.25 to 1.18 (32% change) and a residual-confounding simulation attenuated it by 26% to 1.20 (1.04 to 1.38), i.e. the signal survives its own bias analyses; trim and fill did indicate publication bias, but the calibrated estimate stays positive (1.27, 1.10 to 1.46). Meta-regression cut unexplained heterogeneity to I2=23.4%. The authors' own GRADE: 'The evidence for sugar sweetened beverages was rated as being of moderate quality.' Under an explicit causality assumption, PAF 8.7% (3.9% to 12.9%) of US and 3.6% (1.7% to 5.6%) of UK 10-year T2D events. Observational only - 'causality has not been established'. |
| Qin et al. 2020 · Eur J Epidemiol | meta-analysis | supports | moderate | Dose-response MA: SSB associated with higher T2D, obesity, hypertension, mortality. |
| Schwingshackl, Hoffmann, Lampousi, Knuppel, Iqbal, Schwedhelm, Bechthold, Schlesinger, Boeing 2017 · Eur J Epidemiol 2017;32(5):363-375 | meta-analysis | supports | moderate | Meta-analysis of PROSPECTIVE COHORTS only (no trials), PROSPERO CRD42016037069, 12 a priori food groups; SSB arm = 10 studies, 25,600 incident T2D cases, intake range 0-748 ml/day. 'A significant positive association between T2D and SSB was observed (RR: 1.30; 95% CI 1.20-1.40, I2 = 34%)' and per additional 250 ml/day 'RR: 1.21; 95% CI 1.12-1.31, I2 = 78%, n = 10 studies'. Non-linear p=0.007 but monotone: 'the curve shows an increase of risk of T2D throughout all the range of SSB investigated', i.e. no threshold of safe intake. The low-risk-of-bias subset STRENGTHENED the signal ('stronger positive associations for red meat and SSB intake in the dose-response analyses'), and the authors' own NutriGrade rates SSB meta-evidence 'high'. Held at moderate quality anyway, for three reasons in the paper's own text: the dose-response pool carries I2 = 78%; 'There was significant evidence for small study effects in the dose-response meta-analysis' with 'small studies showing inverse or null association may be missing' (bias pointing the way of our stance); and NutriGrade is this same group's own instrument, not an external audit. No industry funding, 'None of the authors have a conflict of interest to declare.' Contributes NOTHING to the claim's 'only partly explained by weight gain' scope line: no adiposity-mediation or BMI-adjusted analysis is run here. |
| Meng 2021 · Nutrients | meta-analysis | supports | moderate | Dose-response MA: each SSB serving/day associated with higher type-2-diabetes risk. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.